These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11144253)

  • 21. Electron- and positron-emitting radiolanthanides for therapy: aspects of dosimetry and production.
    Uusijärvi H; Bernhardt P; Rösch F; Maecke HR; Forssell-Aronsson E
    J Nucl Med; 2006 May; 47(5):807-14. PubMed ID: 16644751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of medical radioisotopes with linear accelerators.
    Starovoitova VN; Tchelidze L; Wells DP
    Appl Radiat Isot; 2014 Feb; 85():39-44. PubMed ID: 24374071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha- and beta-emitting radiolanthanides in targeted cancer therapy: the potential role of terbium-149.
    Allen BJ; Blagojevic N
    Nucl Med Commun; 1996 Jan; 17(1):40-7. PubMed ID: 8692472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proton and heavy ion acceleration facilities for space radiation research.
    Miller J
    Gravit Space Biol Bull; 2003 Jun; 16(2):19-28. PubMed ID: 12959128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerator physics. The next big beam?
    Clery D
    Science; 2010 Jan; 327(5962):142-3. PubMed ID: 20056871
    [No Abstract]   [Full Text] [Related]  

  • 26. [Photoluminescent and electroluminescent properties of a new rare earth terbium complex].
    Wang L; Zhang XQ; Lin P; Xiong DP; Huang SH; Yu TZ
    Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Jun; 24(6):644-6. PubMed ID: 15766172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production Cross-Section Measurements for Terbium Radionuclides of Medical Interest Produced in Tantalum Targets Irradiated by 0.3 to 1.7 GeV Protons and Corresponding Thick Target Yield Calculations.
    Duchemin C; Cocolios TE; Dockx K; Farooq-Smith GJ; Felden O; Formento-Cavaier R; Gebel R; Köster U; Neumaier B; Scholten B; Spahn I; Spellerberg S; Stamati ME; Stegemann S; Verhoeven H
    Front Med (Lausanne); 2021; 8():625561. PubMed ID: 34055823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Accelerator production of radioisotopes and their utilization in fields other than nuclear medicine].
    Nozaki T
    Radioisotopes; 1987 Apr; 36(4):194-203. PubMed ID: 3497410
    [No Abstract]   [Full Text] [Related]  

  • 29. Toxic effects of heavy metal terbium ion on the composition and functions of cell membrane in horseradish roots.
    Yang Q; Wang L; Zhou Q; Huang X
    Ecotoxicol Environ Saf; 2015 Jan; 111():48-58. PubMed ID: 25450914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Large scale accelerator production of
    Griswold JR; Medvedev DG; Engle JW; Copping R; Fitzsimmons JM; Radchenko V; Cooley JC; Fassbender ME; Denton DL; Murphy KE; Owens AC; Birnbaum ER; John KD; Nortier FM; Stracener DW; Heilbronn LH; Mausner LF; Mirzadeh S
    Appl Radiat Isot; 2016 Dec; 118():366-374. PubMed ID: 27776333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of ion sources for medical accelerators (invited).
    Muramatsu M; Kitagawa A
    Rev Sci Instrum; 2012 Feb; 83(2):02B909. PubMed ID: 22380341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation protection, radiation safety and radiation shielding assessment of HIE-ISOLDE.
    Romanets Y; Bernardes AP; Dorsival A; Gonçalves IF; Kadi Y; di Maria S; Vaz P; Vlachoudis V; Vollaire J
    Radiat Prot Dosimetry; 2013 Jul; 155(3):351-63. PubMed ID: 23516267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation cross-sections of longer lived radioisotopes of proton induced nuclear reactions on terbium up to 65MeV.
    Tárkányi F; Hermanne A; Ditrói F; Takács S; Ignatyuk AV
    Appl Radiat Isot; 2017 Sep; 127():7-15. PubMed ID: 28478333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining Processing Times for Accelerator Produced
    Fitzsimmons J; Griswold J; Medvedev D; Cutler CS; Mausner L
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30897722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consequences of terbium (III) binding on the conformation and enzymatic activity of guinea pig liver transglutaminase.
    Achyuthan KE; Mary A; Bhaerman R; Greenberg CS
    Mol Cell Biochem; 1989 Jan; 85(1):57-65. PubMed ID: 2566905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of the luminescence properties of a novel rare earth complex Tb(DPC)(2)2H2O.
    Lv Y; Li Q; Shi C; Liu H; Liu F; Wu L; Wu D; Liu H; Xie J
    Spectrochim Acta A Mol Biomol Spectrosc; 2009 Sep; 74(1):26-9. PubMed ID: 19577509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of cationic binding sites of neurotoxins from venom of the scorpion (Centruroides sculpturatus Ewing) using lanthanides as binding probes.
    David RM; Krishna NR; Watt DD
    Toxicon; 1991; 29(6):645-62. PubMed ID: 1926166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiobiology with heavy charged particles: a historical review.
    Skarsgard LD
    Phys Med; 1998 Jul; 14 Suppl 1():1-19. PubMed ID: 11542635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Special characteristics and potential for radiopharmaceuticals for positron emission tomography.
    Wolf AP
    Semin Nucl Med; 1981 Jan; 11(1):2-12. PubMed ID: 6972092
    [No Abstract]   [Full Text] [Related]  

  • 40. [Application Status and Development Trends of Medical Proton and Heavy Ion Accelerators].
    Yang X; Chen H; Chen J; Qiao Y; Ma L
    Zhongguo Yi Liao Qi Xie Za Zhi; 2019 Jan; 43(1):37-42. PubMed ID: 30770689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.